Gene Information
Names
HUGO name: CXCR4
Alias(es):
- D2S201E
- HM89
- HSY3RR
- LESTR
- NPY3R
- NPYR
- NPYY3
- NPYY3R
- fusin
- chemokine (C-X-C motif) receptor 4
- neuropeptide Y receptor Y3
- C-X-C chemokine receptor type 4
- Stromal cell- derived factor 1 receptor
- SDF-1 receptor
- Leukocyte-derived seven transmembrane domain receptor
- LCR1
- FB22
- NPYRL
- CD184 antigen
Localization
Reference sequences
- DNA: AF005058 (EMBL)
- cDNA: NM_003467 (EMBL)
- Protein: P30991 (SWISSPROT)
- Other Sequences
Chromosomal location
Maps
Variations / Mutations
Other gene-based resources
Protein Information
Description
Protein function:
Receptor for the c-x-c chemokine sdf-1. Transduces a signal by increasing the intracellular calcium ions level. Involved in haematopoiesis and in cardiac ventricular septum formation. Plays also an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodelling processes in endothelial cells. Could be involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival. Acts as a primary receptor for some HIV-2 isolates and as a co-receptor with CD4 for HIV-1 x4 viruses (lymphocyte-tropic HIV-1 viruses, also called syncytium-inducing (si) strains). Promotes env-mediated fusion of the virus.
Subcellular location:
Integral membrane protein.
Post-translational modification:
Sulfated
Caution:
Was originally thought to be a receptor for neuropeptide y, type 3 (npy3-r).
Structures (PDB)
Domains
Extracellular domain: 1-39
Cytoplasmic domain: 64-79
Extracellular domain: 100-110
Cytoplasmic domain: 133-154
Extracellular domain: 176-200
Cytoplasmic domain: 221-240
Extracellular domain: 262-285
Cytoplasmic domain: 306-352
Other features
N-linked (glcnac...) glycosylation site: 11
Disulfide bond : 109-186
Other related resourses:
Expression
Expression pattern for human
Tissue | Expression (%) | Clones |
---|---|---|
germinal center B-cells | 10.98 | 1:623 |
breast tumor | 8.12 | 1:843 |
normal endometrium, late proliferative phase, cycle day 13 | 6.55 | 1:1044 |
myeloid cells, 18 pooled CML cases, BCR/ABL rearrangement positive, includes both chronic phase and myeloid blast crisis | 5.63 | 2:2431 |
thyroid | 5.11 | 1:1339 |
moderately differentiated adenocarcinoma | 4.44 | 2:3082 |
lymphoma, follicular mixed small and large cell | 3.67 | 5:9317 |
lung tumor | 3.53 | 1:1939 |
lymphocyte | 3.51 | 1:1949 |
serous papillary carcinoma, high grade, 2 pooled tumors | 2.19 | 5:15638 |